← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
CGTBiologicLion TCR Pte. Ltd.Phase 1

Biological: TCR-T (Biological: TCR-T)

Recurrent Hepatocellular Carcinoma · Recurrent Hepatocellular Carcinoma

#RecurrentHepatocellularCarcinoma#CGT#Phase1#인기#세포유전치료+4
효능 ORR 11.8%임상시험 58상태 ACTIVE
CGTBiologicNovartis PharmaceuticalsPhase 2

Bridging Therapy (Bridging Therapy)

Non-Hodgkin Lymphoma · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#CGT#Phase2#인기#세포유전치료+4
효능 ORR 32.1%임상시험 58상태 DISCONTINUED
ADCBiologicAstraZenecaPhase 3

CDK4/6 inhibitor (CDK4/6 inhibitor)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 7.8%임상시험 58상태 RECRUITING
ADCBiologicGlaxoSmithKlinePreclinical

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed)

HIV Infections; Hepatitis B · HIV Infections

#HIVInfections#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 98.1%임상시험 58상태 ACTIVE
CGTBiologicCalimmune, Inc.Phase 1

Gene Modified T Cells (Gene Modified T Cells)

Prostate Cancer · Prostate Cancer

#ProstateCancer#CGT#Phase1#인기#세포유전치료+4
효능 ORR 92.9%임상시험 58상태 DISCONTINUED
CGTBiologicGenentech, Inc.Phase 2

L-Asparaginase (L-Asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+4
효능 ORR 33%임상시험 58상태 RECRUITING
CGTBiologicRoyan InstitutePhase 1

NK cell therapy (NK cell therapy)

Glioblastoma Multiform; Recurrent Glioblastoma · Glioma Glioblastoma Multiforme

#GliomaGlioblastomaMultiforme#CGT#Phase1#인기#세포유전치료+5
효능 ORR 56.3%임상시험 58상태 ACTIVE
ADCBiologicJules Bordet InstituteReleasePhase 2

Neratinib (Neratinib)

Breast Cancer; Brain Metastases · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 57.1%임상시험 58상태 RECRUITING
AntibodyGenentech, Inc.Phase 2

Ocrelizumab (Ocrelizumab)

Rheumatoid Arthritis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase2#인기#항체+5
임상시험 58상태 DISCONTINUED
ADCBiologicJanssen Research & Development,…Phase 2

PEG asparaginase (PEG asparaginase)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · Leukemia

#Leukemia#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 14.3%임상시험 58상태 ACTIVE
CGTBiologicMedigen Vaccine Biologics Corp.Phase 1

Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell, Recombinant Oncolytic HSV-2 Therapeutic Injecta, Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF))

Melanoma Stage IV · Melanoma Stage IV

#MelanomaStageIV#CGT#Phase1#인기#세포유전치료+4
임상시험 58상태 ACTIVE
ADCBiologicAlliance for Clinical Trials in…Phase 3

Thioguanine (Thioguanine)

B Acute Lymphoblastic Leukemia · Leukemia

#Leukemia#ADC#Phase3#인기#항체약물접합체+4
임상시험 58상태 RECRUITING
CGTBiologicGeneplus-Beijing Co. Ltd.Phase 2

natural killer cell infusion (natural killer cell infusion)

Neuroblastoma · Recurrent B-Cell Childhood Acute Lymphob

#RecurrentB-CellChildhoodAcuteLym#CGT#Phase2#인기#세포유전치료+5
효능 ORR 42%임상시험 58상태 ACTIVE
ADCBiologicFondazione per la Medicina Pers…Govitecan Enables a Sequent…Phase 2

talazoparib (talazoparib)

Breast Cancer; Gastrointestinal Cancer · Cancer

#Cancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 27.7%임상시험 58상태 RECRUITING
ADCBiologicEric Thompson, M.D.Phase 1

5-day TMZ (5-day TMZ)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#ADC#Phase1#인기#항체약물접합체+3
효능 ORR 40%임상시험 57상태 DISCONTINUED
ADCBiologicAssistance Publique - Hôpitaux …Phase 2

Adjuvant Systemic Therapy (Adjuvant Systemic Therapy)

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 10%임상시험 57상태 RECRUITING
CGTBiologicCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Fallopian Tube Cancer; Ovarian Cancer · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 5%임상시험 57상태 DISCONTINUED
ADCBiologicAstraZenecaDM1 in Oatp1a/b -/- was 1Phase 2

Cabazitaxel (Cabazitaxel)

Progressive Metastatic Castrate-Resistant Prostate Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 57.7%임상시험 57상태 DISCONTINUED
AntibodyWei-Che KoPhase 3

Canakinumab (Canakinumab)

Skin Inflammation; Allergic Contact Dermatitis · Skin Inflammation

#SkinInflammation#Antibody#Phase3#인기#항체+5
효능 ORR 4.9%임상시험 57상태 RECRUITING
ADCBiologicAmerican Society of Clinical On…Phase 2

Dabrafenib plus Trametinib (Dabrafenib plus Trametinib)

Lymphoma, Non-Hodgkin; Multiple Myeloma · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING

18 / 209 페이지

← 이전다음 →